These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 20813489

  • 21. Inflammatory response in mixed viral-bacterial community-acquired pneumonia.
    Bello S, Mincholé E, Fandos S, Lasierra AB, Ruiz MA, Simon AL, Panadero C, Lapresta C, Menendez R, Torres A.
    BMC Pulm Med; 2014 Jul 29; 14():123. PubMed ID: 25073709
    [Abstract] [Full Text] [Related]

  • 22. [Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].
    Yang J, Dong C, Li J, Zhang H, Zhang H, Song R, Yang Z, Feng F, Qi Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug 29; 26(8):544-8. PubMed ID: 25124901
    [Abstract] [Full Text] [Related]

  • 23. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.
    Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, Kouatchet A, Mourvillier B, Dellamonica J, Picard W, Schmidt M, Boulain T, Brun-Buisson C, A/H1N1 REVA-SRLF Study Group.
    Intensive Care Med; 2011 May 29; 37(5):796-800. PubMed ID: 21369807
    [Abstract] [Full Text] [Related]

  • 24. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I, Georgiadis G, Vogazianos P, Mitis G, Georgiou A.
    Respir Care; 2014 Apr 29; 59(4):574-81. PubMed ID: 24106319
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
    Lee JY, Hwang SJ, Shim JW, Jung HL, Park MS, Woo HY, Shim JY.
    Korean J Lab Med; 2010 Aug 29; 30(4):406-13. PubMed ID: 20805714
    [Abstract] [Full Text] [Related]

  • 26. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
    Cheval C, Timsit JF, Garrouste-Orgeas M, Assicot M, De Jonghe B, Misset B, Bohuon C, Carlet J.
    Intensive Care Med; 2000 Mar 29; 26 Suppl 2():S153-8. PubMed ID: 18470711
    [Abstract] [Full Text] [Related]

  • 27. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.
    Bloos F, Marshall JC, Dellinger RP, Vincent JL, Gutierrez G, Rivers E, Balk RA, Laterre PF, Angus DC, Reinhart K, Brunkhorst FM.
    Crit Care; 2011 Mar 29; 15(2):R88. PubMed ID: 21385367
    [Abstract] [Full Text] [Related]

  • 28. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia.
    Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM.
    Clin Microbiol Infect; 2002 Feb 29; 8(2):93-100. PubMed ID: 11952722
    [Abstract] [Full Text] [Related]

  • 29. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST, Wong EK.
    Intern Med J; 2014 Apr 29; 44(4):390-7. PubMed ID: 24528892
    [Abstract] [Full Text] [Related]

  • 30. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T, CAPNETZ Study Group.
    Eur Respir J; 2008 Feb 29; 31(2):349-55. PubMed ID: 17959641
    [Abstract] [Full Text] [Related]

  • 31. Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.
    Johansson N, Kalin M, Backman-Johansson C, Larsson A, Nilsson K, Hedlund J.
    Scand J Infect Dis; 2014 Nov 29; 46(11):787-91. PubMed ID: 25195651
    [Abstract] [Full Text] [Related]

  • 32. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W, Zhao L, Niu S, Wang S, Sheng B, Zhen J, Gu X, Lyu C.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar 29; 26(3):165-70. PubMed ID: 24598289
    [Abstract] [Full Text] [Related]

  • 33. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH, Wee JH, Choi SP, Oh SH.
    Am J Emerg Med; 2012 Sep 29; 30(7):1248-54. PubMed ID: 22030193
    [Abstract] [Full Text] [Related]

  • 34. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
    Korppi M.
    Pediatr Int; 2004 Oct 29; 46(5):545-50. PubMed ID: 15491381
    [Abstract] [Full Text] [Related]

  • 35. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
    Nascimento-Carvalho CM, Cardoso MR, Barral A, Araújo-Neto CA, Guerin S, Saukkoriipi A, Paldanius M, Vainionpää R, Lebon P, Leinonen M, Ruuskanen O, Gendrel D.
    Scand J Infect Dis; 2010 Sep 29; 42(9):644-9. PubMed ID: 20438288
    [Abstract] [Full Text] [Related]

  • 36. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT.
    Korean J Intern Med; 2009 Dec 29; 24(4):337-42. PubMed ID: 19949732
    [Abstract] [Full Text] [Related]

  • 37. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hartmann O, Marre R, Suttorp N, Welte T, CAPNETZ study group.
    Clin Chim Acta; 2010 Dec 14; 411(23-24):1929-34. PubMed ID: 20699094
    [Abstract] [Full Text] [Related]

  • 38. Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.
    Heppner HJ, Bertsch T, Alber B, Esslinger AS, Dragonas C, Bauer JM, Sieber CC.
    Gerontology; 2010 Dec 14; 56(4):385-9. PubMed ID: 19940454
    [Abstract] [Full Text] [Related]

  • 39. Swine influenza (H1N1) pneumonia: elevated serum procalcitonin levels not due to superimposed bacterial pneumonia.
    Cunha BA, Syed U, Strollo S.
    Int J Antimicrob Agents; 2010 May 14; 35(5):515-6. PubMed ID: 20188520
    [No Abstract] [Full Text] [Related]

  • 40. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
    Julián-Jiménez A, Timón Zapata J, Laserna Mendieta EJ, Parejo Miguez R, Flores Chacartegui M, Gallardo Schall P.
    Med Clin (Barc); 2014 Apr 07; 142(7):285-92. PubMed ID: 24120103
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.